The Cell Lysis And Disruption Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the cell lysis and disruption sector has seen significant growth recently. The market size is projected to rise from $4.91 billion in 2024 to $5.34 billion in 2025, displaying a compound annual growth rate (CAGR) of 8.8%.
The cell lysis and disruption market is forecasted to reach $7.4 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.5%.
Download Your Free Sample of the 2025 Cell Lysis And Disruption Market Report and Uncover Key Trends Now!The cell lysis and disruption market covered in this report is segmented –
1) By Product: Reagents And Consumables, Instruments
2) By Cell Type: Bacteria Cells, Mammalian Cells, Plant Cells, Yeast Or Fungi Or Algae
3) By Application: Cell Organelle Isolation, Protein Isolation, Downstream Processing, Nucleic Acid Isolation
4) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Other End-Users
The key drivers in the cell lysis and disruption marketare:
• Growth of genomics, transcriptomics, and proteomics.
• Increasing applications for single-cell analysis.
• Expansion of funding for academic and research institutes.
• Rising global prevalence of infectious diseases, cancer and chronic diseases.
The key trends in the cell lysis and disruption market are:
• Development of advanced lysis methods is a key trend in the market.
• The automation of sample preparation processes is an emerging trend.
• The integration of lysis tools into lab-on-chip devices is increasingly shaping the market.
• High-throughput cell lysis systems and enhanced buffer formulations for selective lysis are growing trends.
Major companies in the cell lysis and disruption market are:
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Merck KGaA
• Becton Dickinson and Company (BD)
• Agilent Technologies Inc.
• IDEX Corporation
• Bio-Rad Laboratories Inc.
• Qiagen N.V.
• Eppendorf AG
• Miltenyi Biotec GmbH
• Takara Bio Inc.
• Promega Corporation
• New England Biolabs Inc.
• Cell Signaling Technology Inc.
• Covaris LLC
• Microfluidics International Corp.
• Parr Instrument Company
• Pion Inc.
• Analytik Ltd.
• Claremont BioSolutions LLC
• Qsonica LLC
North America was the largest region in the cell lysis and disruption market in 2024